ITV, a broadcast media production company, agreed to invest in Flarin, a pharmaceutical company. Financial terms were not disclosed. “It’s fantastic to be announcing our latest Media for Equity investment into Flarin. With its innovative and patented lipid technology, Flarin offers many unique benefits to those suffering from joint and muscular pain compared to any other product on the market. Flarin is already one of the fastest growing analgesics in the market and I am confident that we will see the company grow to new heights following a brand building campaign across ITV,” Sheena Amin, ITV Director.